CVS Health Corporation
|Company Name||CVS Health Corporation|
|Class Period||February 09, 2016 to February 20, 2019|
|Lead Plaintiff Motion Deadline||April 26, 2019|
On February 20, 2019, CVS announced the Company's fourth quarter and full year financial and operating results and provided 2019 full year guidance. CVS advised investors that adjusted earnings in 2019 would be $6.68 to $6.88 per share, compared with the $7.36 average of market estimates, citing rising costs and poor results related to the Company's 2015 acquisition of Omnicare. On this news, shares of CVS fell $5.66 per share, 8.1%, to close at $64.22 on February 20, 2019, thereby injuring investors.
Submit Your Information
If you suffered a loss on your CVS Health Corporation investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.
An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.